Scientific studies presented at the 4th annual European Society for Sexual and Impotence Research Conference (Rome, Oct. 2001).
Scroppo FI., Mancini M., Maggi M.*, Colpi GM. Andrology Service, Ospedale San Paolo Polo Universitario, Milano (Italy) * Andrology Unit, Dip. Fisiopat. Clin., Universita di Firenze, Firenze (Italy)

Eight patients (age 58.5.3 yrs.) affected by Peyronie's disease, apparently unmodified at least in the latest 3 months and causing penile curvature during erection (PEC), were trained to use a mechanical penis stretcher. None of them complained about erectile dysfunction according to IIEF test, and penile pain. After intracavernous injection of PgE1 5-15 mg to obtain full erection (assessed by both Digital Inflection Rigidometry and palpation), cross scanning of tunica albuginea by duplex sonography, photographs of the erect penis according to Kelami's projections, and penile diameters and length measurements were performed before and after daily home PS application (at least four hours / day) for 3 to 6 months.

Individual follow-up examinations were scheduled after 3 and 6 months. At the present time, all patients have concluded the 3-month follow-up, and two of them the 6-months' one.


Results:

The coat highest thickness resulted 1.8; 0.6 mm before and 1.6;0.3 mm after using the Andropenis (n.s.). The septum latero-lateral maximum thickness was 2.2;0.7 mm before and 1.8;0.8 mm after using the Andropenis (n.s.). Penile length, dorsally measured from penopubic angle to meatus, was 100.5;27.3 mm before and 104.6;22.2 mm after using the Andropenis (n.s.). Photographs showed that PEC decreased from 34.1;4.9; before to 20.0;12.2; after using the Andropenis(p&lgt;0.05). The treatment was well tolerated (no severe complication and no drop out occurred).

Conclusions:

These results suggest a promising use of the Andropenis in selected Peyronie's patients affected by penile curvature without erectile dysfunction.